Molecular imaging of prostate cancer with PET.

@article{Jadvar2013MolecularIO,
  title={Molecular imaging of prostate cancer with PET.},
  author={Hossein Jadvar},
  journal={Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  year={2013},
  volume={54 10},
  pages={1685-8}
}
Molecular imaging is paving the way for precision and personalized medicine. In view of the significant biologic and clinical heterogeneity of prostate cancer, molecular imaging is expected to play an important role in the evaluation of this prevalent disease. The natural history of prostate cancer spans from an indolent localized process to biochemical relapse after radical treatment with curative intent to a lethal castrate-resistant metastatic disease. The ongoing unraveling of the complex… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 2 times. VIEW TWEETS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 32 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 29 references

Competitive advantage of PET/MRI.

European journal of radiology • 2014
View 1 Excerpt

11C-Choline PET/CT and PSA kinetics

European Journal of Nuclear Medicine and Molecular Imaging • 2013
View 1 Excerpt

11C-acetate PET/CT before radical prostatectomy: nodal staging and treatment failure prediction.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine • 2013

Baseline 18F-FDG PET/CT parameters as imaging biomarkers of overall survival in castrate-resistant metastatic prostate cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine • 2013
View 1 Excerpt

Choline PET and PET/CT and biochemical relapse of prostate cancer

L Evangelista, F Zattoni, A Guittilla
Clin Nucl Med • 2013
View 1 Excerpt

Similar Papers

Loading similar papers…